Wilfred Waimiri

Let's give your brand a voice. 

Subscribe

My work

Hi, and welcome to my work page. Here, you will find some of my best work- both as a writer and a publicist. 

I have been privileged to work with companies all over the world, including clients in Australia, the U.S., India, the UK and Canada. I have worked with both B2B and B2C companies. 

Some of the clients I've represented include

  • PRIMITIV- NFL Hall of Famer Calvin Johnson's cannabis brand. 
  • Green Roads- One of the largest CBD Brands. 
  • Vicente LLP- the leading cannabis and psychedelics law firm. 
  • PharmAla- a Canadian biotechnology company dedicated to the domestic research, development and manufacturing of clinical-grade MDMA and novel MDXX. 
  • Dip Devices- a leading manufacturer of multi-functional vape devices, including dab pens, vape pens, 510 thread batteries, and pod vape mods.


I would love to work with your brand. 

Filters & Sorting
ABC57 •

Federal government considering moving marijuana from Schedule I to Schedule III narcotic

Federal government considering moving marijuana from Schedule I to Schedule III narcotic SOUTH BEND, Ind. -- The United States Drug Enforcement Administration is making a move to reclassify marijuana down from a Schedule I narcotic to a Schedule III, according to multiple sources. "The decision comes more than 50 years after cannabis was first listed as a strictly prohibited drug, on par with heroin and defined as a substance with no known medical value and a significant abuse potential," said
Forbes •

FDA Panel Rejects MDMA-Assisted Therapy For PTSD

A U.S. Food and Drug Administration advisory committee voted on Tuesday against approving the use of the psychedelic MDMA in conjunction with therapy as a treatment for post-traumatic stress disorder, saying the available evidence does not show that the drug is effective and that the benefits outweigh the risks. The decision marks a potential setback for supporters of the promising therapy and Lykos Therapeutics, a company formed by the Multidisciplinary Association for Psychedelic Studies (MAPS
Beverage Dynamics •

Introducing Cannabis Beverages Into the On- and Off-Premise Space

As the DEA continues to work to move marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA), the stigma surrounding the substance is slowly but surely subsiding. And the more it subsides, the more cannabis will be accepted in communities across the U.S. Companies like Pamos Cannabis Cocktails & Spirits are working hard to keep diminishing the stigma. Part of what Pamos does is introduce cannabis to consumers in a familiar form: cocktails. In states where it’s legal,
Respect My Region •

Travis Kelce's Kelce Jam Festival Hits Kansas City May 18th

Travis Kelce, the Kansas City Chiefs’ triumphant tight end, is back in town for another round of his epic Kelce Jam, and this year, it’s going to be even bigger. Teaming up once again with Medium Rare and Illicit Gardens, Missouri’s #1 cannabis brand, Kelce promises to shake up Kansas City with a festival experience like no other. Last year’s Kelce Jam was off the charts, featuring Kelce’s now-iconic Lombardi trophy spike and a blazing performance alongside Machine Gun Kelly. This year, the hyp
Oklahoman •

Will the DEA reclassify marijuana as a Schedule III drug? What change means for Oklahoma

About six years ago, Oklahomans voted to legalize medical marijuana in the state. Now, the U.S. Drug and Enforcement Administration is debating reclassifying weed as a less dangerous substance. USA Today reported that marijuana could be reclassified under the Controlled Substances Act from a Schedule I drug to a Schedule III drug. Marijuana has been considered a Schedule I drug since the Controlled Substances Act was signed in 1970, falling into the same category as substances like heroin, MDMA

New Mexico Governor Calls Homeland Security Secretary’s Response to Pot Seizures ‘Inappropriate’

New Mexico Governor Michelle Lujan Grisham expressed frustration with Department of Homeland Security Secretary Alejandro Mayorkas in a recent phone call with an unidentified federal official, saying she was “offended” by his response to seizures of weed from licensed marijuana companies. At least a dozen seizures of regulated cannabis by Customs and Border Protection (CBP) agents have been reported at immigration checkpoints in southern New Mexico in recent weeks, despite the 2021 legalization
Macon Telegraph •

DEA’s big marijuana shift could be a lifeline for California’s troubled pot industry

If the U.S. Drug Enforcement Administration reclassified marijuana as a less dangerous drug, it wouldn't eliminate the conflicts between the feds and states such as California that have legalized many uses of the substance. But it would bring one significant shift that could give California's licensed pot companies a badly needed boost: a lighter tax burden. The Associated Press reported Tuesday that the Drug Enforcement Administration will propose moving marijuana from the list of Schedule I
The Augusta Chronicle •

Biden administration plans to reclassify marijuana. What does that mean for Georgia?

Biden administration plans to reclassify marijuana. What does that mean for Georgia? A change in policy could be coming that would dramatically change how weed is perceived and criminalized in America. USA Today reported that the U.S. Drug and Enforcement Administration is debating reclassifying marijuana under the Controlled Substances Act from a Schedule I drug to a Schedule III drug. It's been considered a Schedule I drug since the Controlled Substances Act was signed in 1970, falling into
Los Angeles Times •

DEA's big marijuana shift could be a lifeline for California's troubled pot industry

Marijuana plants reflect the ultraviolet light that helps the plants grow inside the “clone cube” at the Artist Tree in West Hollywood in 2024. The plants inside the “clone cube” are available for purchase by customers. The cannabis company has continued to expand as many others in the industry are closing. If the U.S. Drug Enforcement Administration reclassified marijuana as a less dangerous drug, it wouldn’t eliminate the conflicts between the feds and states such as California that have lega
Miami Herald •

DEA’s big marijuana shift could be a lifeline for California’s troubled pot industry

If the U.S. Drug Enforcement Administration reclassified marijuana as a less dangerous drug, it wouldn't eliminate the conflicts between the feds and states such as California that have legalized many uses of the substance. But it would bring one significant shift that could give California's licensed pot companies a badly needed boost: a lighter tax burden. The Associated Press reported Tuesday that the Drug Enforcement Administration will propose moving marijuana from the list of Schedule I
Fresno Bee •

DEA’s big marijuana shift could be a lifeline for California’s troubled pot industry

If the U.S. Drug Enforcement Administration reclassified marijuana as a less dangerous drug, it wouldn't eliminate the conflicts between the feds and states such as California that have legalized many uses of the substance. But it would bring one significant shift that could give California's licensed pot companies a badly needed boost: a lighter tax burden. The Associated Press reported Tuesday that the Drug Enforcement Administration will propose moving marijuana from the list of Schedule I
Idaho Statesman •

DEA’s big marijuana shift could be a lifeline for California’s troubled pot industry

If the U.S. Drug Enforcement Administration reclassified marijuana as a less dangerous drug, it wouldn't eliminate the conflicts between the feds and states such as California that have legalized many uses of the substance. But it would bring one significant shift that could give California's licensed pot companies a badly needed boost: a lighter tax burden. The Associated Press reported Tuesday that the Drug Enforcement Administration will propose moving marijuana from the list of Schedule I
Green Market Report •

Cannabis industry views DEA news as a ‘positive step,’ but more work lies ahead

Corporate cannabis, small business owners, and advocates alike had a lot to say on Tuesday, after the U.S. Drug Enforcement Administration confirmed it will put forth a proposal to reschedule cannabis from its current Schedule I classification to Schedule III under the Controlled Substances Act. The proposed rule, which would recognize cannabis as having a lower potential for abuse compared to its current status, will have to first undergo a review by the White House Office of Management and Bu
Benzinga •

How Industry Leaders Reacted to DEA Cannabis Rescheduling - MariMed (OTC:MRMD), Indoor Harvest (OTC:INQD)

In a landmark decision, the U.S. Drug Enforcement Administration (DEA) is reportedly moving cannabis from Schedule I to Schedule III under the Controlled Substances Act, sparking varied reactions across the industry. MariMed’s MRMD Enthusiastic Endorsement Bob Fireman, CEO of MariMed, expressed his excitement about the decision: "The impending announcement of the DEA's decision to recategorize cannabis…is historic. The positive impact this will have cannot be overstated. Our industry, the milli
Newsweek •

Biden admin moves to declare marijuana as safe as some Tylenol

The U.S. Drug Enforcement Administration (DEA) plans to reclassify marijuana as a Schedule III drug, a category that includes Tylenol with codeine, once its proposal has been reviewed by the White House Office of Management and Budget. As of 2024, marijuana has become legalized for recreational use in 24 states, with 38 permitting its use in medical contexts. In December 2022, President Joe Biden moved to pardon all U.S. citizens who had been convicted of simple possession, attempted simple pos
Load More Articles

Subscribe to get sent a digest of new articles by Wilfred Waimiri

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

One-click unsubscribe anytime, your email will not be used for anything else.